PRE 14A

PRE 14A Filing

Company: Corbus Pharmaceuticals Holdings, Inc.
Filed: March 26, 2021
Period of Report: March 26, 2021
Accession Number: 0001493152-21-006927

View Document ↗ View on SEC.gov ↗